Benzodiazepine use in COPD: empirical evidence from Norway
Thomas Halvorsen,1 Pål E Martinussen21SINTEF Technology and Society, Department for Health Research, 2Department of Sociology and Political Science, Norwegian University of Science and Technology, Trondheim, NorwayBackground: The common comorbidities associated with COPD include,...
Main Authors: | Halvorsen T, Martinussen PE |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2015-08-01
|
Series: | International Journal of COPD |
Online Access: | http://www.dovepress.com/benzodiazepine-use-in-copd-empirical-evidence-from-norway-peer-reviewed-article-COPD |
Similar Items
-
Where and why do firms choose to move? Empirical evidence from Norway
by: Oyvind Lervik Nilsen, et al.
Published: (2020-08-01) -
1,4-Benzodiazepine N-Nitrosoamidines: Useful Intermediates in the Synthesis of Tricyclic Benzodiazepines
by: Carlos del Pozo, et al.
Published: (2006-08-01) -
Benzodiazepine use and the risk of dementia
by: Geoffrey Joyce, et al.
Published: (2022-01-01) -
Pattern of Benzodiazepine use in Nurses
by: Shajaat Ali Khan, et al.
Published: (2010-12-01) -
Adolescents’ experiences of the information they received about the coronavirus (Covid-19) in Norway: a cross-sectional study
by: Sabine Kaiser, et al.
Published: (2021-06-01)